NYSE ARCA | ETF
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization.
Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry ("health care companies").
It is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 17.71% |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 14.15% |
LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 6.89% |
UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 6.74% |
PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 4.71% |
MASI | Masimo Corporation | Healthcare | Medical Devices | 4.04% |
DXCM | DexCom Inc | Healthcare | Medical Devices | 3.70% |
SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 3.55% |
RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 3.30% |
HUM | Humana Inc | Healthcare | Healthcare Plans | 2.87% |
WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 2.87% |
NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.59% |
ICLR | ICON PLC | Healthcare | Diagnostics & Research | 2.50% |
ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.40% |
6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 2.39% |
CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.32% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.25% |
MLTX_old | Multex Com Inc | Other | Other | 2.24% |
MRUS | Merus BV | Healthcare | Biotechnology | 2.22% |
LNTH | Lantheus Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.17% |